Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Winthrox Laboratories Pvt. Ltd

Pharmaceutical manufacturer · Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Regulatory & corporate identity

Company profile

Not yet verified
Company type
Pharmaceutical manufacturer
DRAP-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000807 125 linked products · source seen 10 Aug 2026 View source ↗
Location intelligence

Company location

Google Maps
Exact site not yet verified

MedInfoBase will not invent a factory or office location. The map appears after a sourced address, Place ID or verified embed URL is added.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx125product presentations
G45generic molecules
DF8dosage-form groups
TA13therapeutic areas
PKR125current price records
REG88registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage88%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixWinthrox Laboratories Pvt. LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/winthrox-laboratories-pvt-ltdGenerated 10 Aug 2026Anti-infectives61 · 49%CNS & mental health20 · 16%Vitamins, minerals & nutrition15 · 12%Fluids & supportive care7 · 6%Gastrointestinal & hepatology6 · 5%Pain & musculoskeletal5 · 4%Dermatology2 · 2%Other therapeutic areas9 · 7%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioWinthrox Laboratories Pvt. LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/winthrox-laboratories-pvt-ltdGenerated 10 Aug 2026125presentationsTablet41 · 33%Injection33 · 26%Suspension17 · 14%Syrup10 · 8%Drops8 · 6%Capsule7 · 6%Other forms9 · 7%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent-Market Price Position

Shows whether safely comparable products are below, near or above the market median unit price.

Equivalent-Market Price PositionWinthrox Laboratories Pvt. LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/winthrox-laboratories-pvt-ltdGenerated 10 Aug 2026110comparable productsBelow market median46 · 42%Near market median18 · 16%Above market median46 · 42%Company median price position+3.1%Lowest-price equivalents12Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsWinthrox Laboratories Pvt. LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/winthrox-laboratories-pvt-ltdGenerated 10 Aug 2026Pharmasol (Pvt) Ltd.31 shared69% overlapM/s. Genix Pharma (Pvt) Ltd.28 shared62% overlapMediate Pharmaceutical Pvt Ltd28 shared62% overlapBio-Labs(Pvt) Ltd28 shared62% overlapNeutro Pharma (Pvt.) Ltd.,28 shared62% overlapMacter International Limited27 shared60% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives61 products · 49%
CNS & mental health20 products · 16%
Vitamins, minerals & nutrition15 products · 12%
Fluids & supportive care7 products · 6%
Gastrointestinal & hepatology6 products · 5%
Pain & musculoskeletal5 products · 4%
Dermatology2 products · 2%
Hematology & thrombosis2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antiepileptics20 products · 16%
Third-generation cephalosporins17 products · 14%
Vitamins / minerals / hematinics15 products · 12%
Macrolide antibacterials12 products · 10%
Antimalarials10 products · 8%
Fluoroquinolone antibacterials8 products · 6%
Fluids, electrolytes & diluents7 products · 6%
Penicillin antibacterials6 products · 5%
Formulation footprint

Dosage forms

Tablet41 products
Injection33 products
Suspension17 products
Syrup10 products
Drops8 products
Capsule7 products
Solution5 products
Sachet4 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 LivilipLevetiracetam 10presentations 100 mg/mL, 250 mg, 500 mg, 500 mg/5 mL · Solution, Tablet, Injection #2 WapivalDivalproex sodium 8presentations 250 mg, 500 mg · Tablet #3 AudyCeftriaxone 6presentations 1000 mg, 2 g, 250 mg, 500 mg · Injection #4 WinkidofenIbuprofen 5presentations 100 mg/5 mL, 200 mg/5 mL · Syrup, Suspension #5 WintekClarithromycin 5presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #6 WintermArtemether + Lumefantrine 5presentations 40 mg + 240 mg, 80 mg + 480 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median4642% of comparable products
Near market median18within ±5% of median
Above market median4642% of comparable products
Lowest-price equivalents12ties included
Company median price position +3.1% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Livilip 500 mg/5 mLLevetiracetam · Injection · 5ml x10's PKR 68.97/mL-47.0% vs market median Livilip 100 mg/mLLevetiracetam · Oral solution · 120ml PKR 7.32/mL-45.7% vs market median Livilip 100 mg/mLLevetiracetam · Oral solution · 60ml PKR 7.32/mL-45.7% vs market median Livilip 500 mgLevetiracetam · Tablet · 30's PKR 53.06/tablet-43.6% vs market median Livilip 100 mg/mLLevetiracetam · Oral solution · 30ml PKR 7.73/mL-42.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Pharmasol (Pvt) Ltd.251 products · 101 generics 31shared generics M/s. Genix Pharma (Pvt) Ltd.290 products · 97 generics 28shared generics Mediate Pharmaceutical Pvt Ltd239 products · 90 generics 28shared generics Bio-Labs(Pvt) Ltd234 products · 82 generics 28shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 28shared generics Macter International Limited248 products · 91 generics 27shared generics
Regulatory & price activity

Observed database signals

Registration numbers88
Price-history records157
Products with price history23
Source records with multiple versions0
Latest MedInfoBase verification10 Aug 2026
Latest effective price date10 Aug 2026
Latest source observation10 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

8 results
Intelligence filter: Therapeutic areaAnti-infectives Drug classFluoroquinolone antibacterials Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Biorim Ciprofloxacin 3 mg Ophthalmic drops 5ml 100489 PKR 223.65 PKR 44.73/mL No comparator
Moxpin Moxifloxacin 400 mg Tablet 5's 074931 PKR 994.48 PKR 198.90/tablet 10% above median
Oflolon Ofloxacin 3 mg Ophthalmic drops 5ml 101208 PKR 165.21 PKR 33.04/mL No comparator
Wincip Ciprofloxacin 500 mg Tablet 10's 074926 PKR 444.00 PKR 44.40/tablet 6% above median
Wincip Ciprofloxacin 250 mg Tablet 10's 074925 PKR 268.46 PKR 26.85/tablet 6% above median
Wincip Ciprofloxacin 250 mg/5 mL Oral suspension 60ml 098618 PKR 330.42 PKR 5.51/mL 29% above median
Winflox Levofloxacin 250 mg Tablet 10's 074927 PKR 516.28 PKR 51.63/tablet 9% above median
Winflox Levofloxacin 500 mg Tablet 10's 074928 PKR 859.08 PKR 85.91/tablet 9% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.